Sign in
4

Changes in Ownership

Arcadia Biosciences, Inc. Filed Acc 0001209191-21-005219

Chief Executive Officer bought 585 shares at $3.16 ($1,849)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Plavan Matthew T Chief Executive Officer 2020-08-03 Purchase +585 $3.16 $1,849 14,285 D
Derivatives
Plavan Matthew T Chief Executive Officer 2021-01-21 Grant or award · Stock Option (right to buy) +250,000 435,450 D
Open-market purchases · 585 sh · avg $3.16 · $1,849
Loading xslF345X03/doc4.xml…